 Ltd. logo1.jpg){kind=logo}
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 22.29 % in the past year, substantial increase in net sales/revenue by 14.48 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -54.21 %, Marginal decrease of -31.87% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Syncom Formulations (India) Limited. Profit dropped by -12.62 % Year to Year, Syncom Formulations (India) Limited’s profitability increased by 5.76 % in this quarter.
- EPS over the Year and quarter: EPS increased by 0.00 % Year to Year. EPS increased by 11.11 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 60.98 Cr | Rs. 65.14 Cr | Rs. 74.573 Cr | + 14.48 % | + 22.29 % |
| Expenses | Rs. 55.02 Cr | Rs. 57.78 Cr | Rs. 65.14 Cr | + 12.74 % | + 18.39 % |
| Operating Profit | Rs. 5.96 Cr | Rs. 7.36 Cr | Rs. 9.43 Cr | + 28.13 % | + 58.22 % |
| OPM % | 9.77 % | 11.3 % | 12.65 % | + 1.35 % | + 2.88 % |
| Other Income | Rs. 6.77 Cr | Rs. 4.55 Cr | Rs. 3.1 Cr | -31.87 % | -54.21 % |
| Interest | Rs. 1.29 Cr | Rs. 1.08 Cr | Rs. 1.2 Cr | + 11.11 % | -6.98 % |
| Depreciation | Rs. 1.17 Cr | Rs. 1.45 Cr | Rs. 1.3 Cr | -10.34 % | + 11.11 % |
| Profit before tax | Rs. 10.27 Cr | Rs. 9.38 Cr | Rs. 10.03 Cr | + 6.93 % | -2.34 % |
| Tax % | 17.6 % | 25.21 % | 26.18 % | + 0.97 % | + 8.58 % |
| Net Profit | Rs. 8.47 Cr | Rs. 7 Cr | Rs. 7.41 Cr | + 5.86 % | -12.51 % |
| EPS in Rs | Rs. 0.1 | Rs. 0.09 | Rs. 0.1 | + 11.11 % | + 0 % |
Today, we’re looking at Syncom Formulations (India) Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 22.29 %. However, it did see a marginal increase of 14.48 % from the previous quarter. Expenses ticked up slightly by 12.74 % quarter-on-quarter, aligning with the annual rise of 18.39 %. Operating profit, while up 58.22 % compared to last year, faced a quarter-on-quarter increase of 28.13 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.88 %, but an expansion of 1.35 % sequentially. Other income fell by -31.87 % compared to the last quarter, despite an annual decline of -54.21 %. Interest expenses surged remarkably by 11.11 % from the previous quarter, yet the year-over-year decrease remains at a moderate -6.98 %. Depreciation costs fell by -10.34 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 11.11 %. Profit before tax declined annually by -2.34 % but saw an increase from the preceding quarter by 6.93 %.
Tax expenses as a percentage of profits increased slightly by 8.58 % compared to last year, with a more notable quarter-on-quarter increase of 0.97 %. Net profit fell by -12.51 % year-on-year but experienced a 5.86 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 0 % but a quarterly rise of 11.11 %. In summary, Syncom Formulations (India) Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 60.98 Cr | Rs. 65.14 Cr | Rs. 74.573 Cr | + 14.48 % | + 22.29 % |
| Expenses | Rs. 55.02 Cr | Rs. 57.78 Cr | Rs. 65.14 Cr | + 12.74 % | + 18.39 % |
| Operating Profit | Rs. 5.96 Cr | Rs. 7.36 Cr | Rs. 9.43 Cr | + 28.13 % | + 58.22 % |
| Net Profit | Rs. 8.47 Cr | Rs. 7 Cr | Rs. 7.41 Cr | + 5.86 % | -12.51 % |
| EPS in Rs | Rs. 0.1 | Rs. 0.09 | Rs. 0.1 | + 11.11 % | + 0 % |
In reviewing Syncom Formulations (India) Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 22.29 % year-on-year growth, however, there was a minor increase of 14.48 % from the previous quarter. Expenses rose by 18.39 % compared to the previous year, with a 12.74 % increase quarter-on-quarter. Operating Profit surged by 58.22 % annually, and saw a 28.13 % increase from the last quarter.
Net Profit showed yearly decrease of -12.51 %, and experienced a 5.86 % increase from the previous quarter. Earnings Per Share (EPS) rose by 0 % annually, however rose by 11.11 % compared to the last quarter. In essence, while Syncom Formulations (India) Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
